February 06, 2017
The Jefferies Group investment bank is arguing that shareholders who bought stock in a since-failed biotech company because of the firm's recommendation cannot force it into arbitration before the Financial Industry Regulatory Authority over the stock's loss of value, according to a suit filed Friday in Texas federal court.